Neuburgh Advisers LLC Buys 2,080 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Neuburgh Advisers LLC grew its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 419.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,576 shares of the technology company’s stock after acquiring an additional 2,080 shares during the quarter. Neuburgh Advisers LLC’s holdings in Simulations Plus were worth $74,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the company. Dimensional Fund Advisors LP increased its holdings in shares of Simulations Plus by 4.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 571,865 shares of the technology company’s stock valued at $11,380,000 after acquiring an additional 25,871 shares in the last quarter. William Blair Investment Management LLC boosted its position in shares of Simulations Plus by 8.8% during the first quarter. William Blair Investment Management LLC now owns 485,040 shares of the technology company’s stock valued at $10,239,000 after buying an additional 39,114 shares during the last quarter. Crawford Investment Counsel Inc. boosted its position in shares of Simulations Plus by 6.0% during the first quarter. Crawford Investment Counsel Inc. now owns 355,057 shares of the technology company’s stock valued at $7,495,000 after buying an additional 20,009 shares during the last quarter. Wasatch Advisors Inc. boosted its position in shares of Simulations Plus by 15.6% during the first quarter. Wasatch Advisors Inc. now owns 343,122 shares of the technology company’s stock valued at $7,243,000 after buying an additional 46,310 shares during the last quarter. Finally, Royce & Associates LP boosted its position in shares of Simulations Plus by 206.5% during the first quarter. Royce & Associates LP now owns 155,408 shares of the technology company’s stock valued at $3,281,000 after buying an additional 104,696 shares during the last quarter. Hedge funds and other institutional investors own 41.97% of the company’s stock.

In other news, Director John Kenneth Paglia sold 690 shares of Simulations Plus stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $37.86, for a total transaction of $26,123.40. Following the transaction, the director now directly owns 2,112 shares of the company’s stock, valued at approximately $79,960.32. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Walter S. Woltosz sold 24,000 shares of Simulations Plus stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $36.22, for a total value of $869,280.00. The disclosure for this sale can be found here. Company insiders own 31.57% of the company’s stock.

Shares of Simulations Plus stock traded down $0.26 during trading on Friday, hitting $34.38. 2,535 shares of the company’s stock traded hands, compared to its average volume of 114,977. Simulations Plus, Inc. has a 1 year low of $17.18 and a 1 year high of $41.95. The stock has a market capitalization of $585.90 million, a P/E ratio of 68.80 and a beta of -0.35. The business has a 50-day simple moving average of $36.95 and a 200-day simple moving average of $27.58.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Wednesday, July 10th. The technology company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.02. The business had revenue of $9.94 million for the quarter, compared to analysts’ expectations of $9.85 million. Simulations Plus had a return on equity of 23.48% and a net margin of 24.09%. Research analysts expect that Simulations Plus, Inc. will post 0.46 EPS for the current year.

SLP has been the topic of several recent analyst reports. BidaskClub cut Simulations Plus from a “strong-buy” rating to a “buy” rating in a research report on Tuesday. ValuEngine cut Simulations Plus from a “strong-buy” rating to a “buy” rating in a research report on Friday, August 2nd. Finally, Zacks Investment Research raised Simulations Plus from a “hold” rating to a “strong-buy” rating and set a $37.00 price objective on the stock in a research report on Friday, July 19th.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.

Featured Story: Day Trading

Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP).

Institutional Ownership by Quarter for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit